| Literature DB >> 30825283 |
Huimei Wang1, Arezoo Khoradmehr2, Amin Tamadon3.
Abstract
Major biological processes rely on the spatial organization of cells in complex, highly orchestrated three-dimensional (3D) tissues. Until the recent decade, most of information on spatial neural representation primarily came from microscopic imaging of "2D" (5-50 μm) tissue using traditional immunohistochemical techniques. However, serially sectioned and imaged tissue sections for tissue visualization can lead to unique non-linear deformations, which dramatically hinders scientists' insight into the structural organization of intact organs. An emerging technique known as CLARITY renders large-scale biological tissues transparent for 3D phenotype mapping and thereby, greatly facilitates structure-function relationships analyses. Since then, numerous modifications and improvements have been reported to push the boundaries of knowledge on tissue clearing techniques in research on assembled biological systems. This review aims to outline our current knowledge on next-generation protocols of fast free-of-acrylamide clearing tissue (FACT) and passive CLARITY (PACT). The most important question is what method we should select for tissue clearing, FACT or PACT. This review also highlights how FACT differs from PACT on spanning multiple dimensions of the workflow. We systematically compared a number of factors including hydrogel formation, clearing solution, and clearing temperatures between free-acrylamide and acrylamide-based passive sodium dodecyl sulfate (SDS) tissue clearing and discussed negative effects of polyacrylamide on clearing, staining, and imaging in detail. Such information may help to gain a perspective for interrogating neural circuits spatial interactions between molecules and cells and provide guidance for developing novel tissue clearing strategies to probe deeply into intact organ. Copyright© by Royan Institute. All rights reserved.Entities:
Keywords: Acrylamide; Imaging; Staining and Labeling; Three-Dimensional; Tissues
Year: 2019 PMID: 30825283 PMCID: PMC6397597 DOI: 10.22074/cellj.2019.5989
Source DB: PubMed Journal: Cell J ISSN: 2228-5806 Impact factor: 2.479
Successful applications of the passive CLARITY protocol for tissue clearing and three-dimensional imaging
| Tissue/organ | Species | Hydrogel perfusion/embedding | Clearing solution | Clearing time | RI* homogenization | References |
|---|---|---|---|---|---|---|
| Skeletal muscle (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 42 days (adult) | 80% glycerol | ( |
| Brain (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 21 days (adult) | FocusClear/85-87% glycerol | ( |
| Brain (section) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 7 days (adult) | PBST | ( |
| Brain (whole)/lung (whole)/testis (whole)/kidney (whole)/intestine (whole)/spleen (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 30 days (adult) | FocusClear/80% glycerol | ( |
| Brain (whole)/spinal cord (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 28-42 days (adult brain)/14-28 days (adult spinal cord) | TDE | ( |
| Brain (whole)/spinal cord (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=7.5) | 36 days (adult brain)/21 days (adult spinal cord) | FocusClear | ( |
| Brain (section)/spinal cord (section) | Mouse/rat | +/+ | 8% SDS in boric acid (pH=7.5) | 4 days (adult mouse)/6 days (adult rat) | 80% Glycerol/65% TDE | ( |
| Brain (whole) | Rat | +/+ | 4% SDS in boric acid (pH=8.5) | 28-56 days (adult) | RapiClear | ( |
| Brain (section) | Rat | +/+ | 4% SDS in boric acid (pH=8.5) | 6 days (age P0) to 20 days (age P24) | TDE | ( |
| Brain (section) | Human | −/+ | 4% SDS in boric acid (pH=8.5) | 14 days (adult) | ScaleA2 solution | ( |
| Brain (whole) | Mouse/rat /human (section) | +/+ | 4% SDS in boric acid (pH=8.5) | 21 days (adult mouse)/60 days (adult rat)/5-10 days (adult human) | 87% glycerol/ScaleA2 solution | ( |
| Cerebellum (whole) | Mouse/human (section) | −/+ | 4% SDS in boric acid (pH=8.5) | 7 days (adult mouse)/>28 days (human adult) | RIMS+PBS+Tween-20 | ( |
| Spinal cord (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=7.5) | 14 days (adult) | CUBIC clearing solution | ( |
| Whole body | Zebrafish | -/+ | 8% SDS in boric acid (pH=8.5) | 5-7 days (adult) | RIMS | ( |
| Fetus (whole)/brain (whole)/lung (whole)/heart (whole)/kidney (whole)/muscle† (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 3-10 days (fetus)/10 days (other tissues) | RIMS | ( |
| Liver (section) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 30 days (adult) | RIMS | ( |
| Retina | Rat | −/+ | 4% SDS | 5 days | RIMS | ( |
| Lung (whole) | Mouse | −/+ | 8% SDS in boric acid (pH=8.5) | ND | RIMS | ( |
| Intestine (section) | Mouse/human | +/+ | 4% SDS in boric acid (pH=8.5) | 12-14 days (adult) | 80% glycerol | ( |
| Ovary (whole) | Mouse | +/+ | 4% SDS in boric acid (pH=8.5) | 35 days (adult) | FocusClear | ( |
| Testis (whole) | Zebrafish | −/+ | 8% SDS in boric acid (pH=8.5) | 13 days (adult) | RIMS | ( |
| Stem-cell-derived cortical cultures | Mouse | ND | ND | ND | ND | ( |
RI; Refractive index, SDS; Sodium dodecyl sulfate, TDE; 2,20-thiodiethanol, RIMS; Refractive index matching solution, PBS; Phosphate-buffered saline, ND; No data, PBST; Phosphate-buffered saline+Triton X-100, and †; The passive CLARITY was performed on muscle until the clearing stage and without immunolabelling and imaging.
Application of successful PACT for different tissue clearing and three-dimensional imaging
| Tissue/organ | Species | Hydrogel perfusion/embedding | Clearing solution | Clearing time | RI*homogenization | References |
|---|---|---|---|---|---|---|
| Brain (whole/section)/kidney (section)/heart (section)/lung (section)/intestine (section)/basal cell carcinoma (section) | Mouse/human | +/+ | 8% SDS in PBS (pH=7.5) | 3-14 days (adult mouse brain)/ND (other tissues) | 80% glycerol/RIMS/ sRIMS | ( |
| Fetus (whole)/brain (whole)/lung (whole)/heart (whole)/kidney (whole)/muscle† (whole) | Mouse | +/+ | 8% SDS in PBS (pH=7.5) | 3-10 days (fetus)/25-30 days (other adult tissues) | RIMS | ( |
| Brain (whole)/spinal cord (whole)/lung (whole)/heart (whole)/liver (whole)/stomach (whole)/salivary gland (whole)/pancreas (whole)/fetus (whole)/spleen (whole)/parotid gland (whole)/genital organ (whole)/kidney (whole)/bone (whole) | Mouse/Rat/Guinea Pig | +/+ | 8% SDS in PBS (pH=7.5) | 17-23 days (adult) | nRIMS | ( |
| Brain (section) | Mouse | -/+ | 8% SDS in PBS (pH=7.6) | 1-3 days (adult) | RIMS | ( |
| Intestine (section) | Mouse/ human | +/+ | 8% SDS in PBS (pH=7.5) | 12-14 days (adult) | 80% glycerol | ( |
| Mammary gland (whole)/mammary tumor | Mouse | +/+ | 8% SDS in distilled water (pH=7.5) | 4 days (adult) | sRIMS | ( |
RI; Refractive index, SDS; Sodium dodecyl sulfate, PBS; Phosphate buffer saline, PBST; Phosphate buffer saline+triton X100, RIMS; Refractive index matching solution, nRIMS; Nycodenz-based refractive index media solution, sRIMS; Sorbitol-based refractive index matching solution, TDE; 2,20-thiodiethanol, ND; No data, and †; The PACT is done on muscle until clearing stage and without immune-labeling and imaging.
Fig.3Chemical mechanisms through which paraformaldehyde crosslinks proteins. Images were adapted with permission (24).
Application of successful free-acrylamide tissue clearing for different tissue clearing and three-dimensional imaging
| Tissue/organ | Species | Hydrogel perfusion/embedding | Clearing solution | Clearing time | RI* homogenization | References |
|---|---|---|---|---|---|---|
| Brain (section) | Mouse | -/- | 8% SDS in PBS (pH=7.5) | 3 days | FocusClear | ( |
| Brain (section) | Mouse/human | -/- | 4% SDS in sodium borate buffer | 40 days(human)/ND (other tissues) | Histodenz-RIMS(mouse)47% 2,2’-Thidiethanol in 10 mM phosphate buffer (human)/ND (other tissues) | ( |
| Brain (section) | Human | -/- | 4% SDS in sodium borate buffer | Minimum of 5 days | FASTClear | ( |
| Heart (section) | Dog/human | -/- | 4% SDS buf fer | 4 day | FASTClear | ( |
RI; Refractive index, SDS; Sodium dodecyl sulfate, PBS; Phosphate buffer saline, RIMS; Refractive index matching solution, and ND; No data.